CVS Health Corp (CVS) : Landscape Capital Management L.l.c. scooped up 50,160 additional shares in CVS Health Corp during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 11, 2016. The investment management firm now holds a total of 77,510 shares of CVS Health Corp which is valued at $8 Million.CVS Health Corp makes up approximately 0.99% of Landscape Capital Management L.l.c.’s portfolio.
Other Hedge Funds, Including , Gareth Morgan Investments Limited Partnership boosted its stake in CVS in the latest quarter, The investment management firm added 24,799 additional shares and now holds a total of 113,347 shares of CVS Health Corp which is valued at $11.8 Million. CVS Health Corp makes up approx 1.22% of Gareth Morgan Investments Limited Partnership’s portfolio.Td Asset Management Inc reduced its stake in CVS by selling 1,068,409 shares or 38.22% in the most recent quarter. The Hedge Fund company now holds 1,726,705 shares of CVS which is valued at $181 Million. CVS Health Corp makes up approx 0.34% of Td Asset Management Inc’s portfolio.Hudock Capital Group reduced its stake in CVS by selling 157 shares or 22.11% in the most recent quarter. The Hedge Fund company now holds 553 shares of CVS which is valued at $57,982. CVS Health Corp makes up approx 0.03% of Hudock Capital Group’s portfolio.Argyle Capital Management reduced its stake in CVS by selling 450 shares or 3.21% in the most recent quarter. The Hedge Fund company now holds 13,582 shares of CVS which is valued at $1.4 Million. CVS Health Corp makes up approx 0.61% of Argyle Capital Management’s portfolio.
CVS Health Corp opened for trading at $103.67 and hit $104.76 on the upside on Monday, eventually ending the session at $104.55, with a gain of 0.85% or 0.88 points. The heightened volatility saw the trading volume jump to 28,22,445 shares. Company has a market cap of $112,289 M.
On the company’s financial health, CVS Health Corp reported $1.18 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on May 3, 2016. Analyst had a consensus of $1.16. The company had revenue of $43215.00 million for the quarter, compared to analysts expectations of $43000.77 million. The company’s revenue was up 18.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.14 EPS.
Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Mizuho on May 4, 2016 to “Buy”, Firm has raised the Price Target to $ 117 from a previous price target of $104 .Company shares were Reiterated by RBC Capital Mkts on May 4, 2016 to “Outperform”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .Company shares were Reiterated by Barclays on Mar 10, 2016 to “Overweight”, Firm has raised the Price Target to $ 115 from a previous price target of $110 .
CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.